Steven Warner, PhD

My research in the Medicinal and Natural Products Chemistry Program focused on the validation and drug targeting of the Aurora kinases to treat cancer. I used genetic and pharmacological approaches to perturb the Aurora kinase signaling pathway in order to understand the biological consequences and potential clinical outcomes of an Aurora-targeted therapy. Additionally, I employed a structure-based approach to design and develop a novel class of small molecule Aurora kinase inhibitors. I am currently a manager in Discovery Biology at SuperGen, Inc.
Status: 
Alumni
Degree: 
PhD
Program: 
Pharmaceutical Sciences
Track: 
Drug Discovery and Development
Dissertation Title: 
"Targeting the Aurora Kinases to Treat Pancreatic Cancer"
Publications: 
1. S.L. Warner, H. Han, D.J. Bearss and D.D. Von Hoff. Targeting Aurora-2 kinase in cancer. Molecular Cancer Therapeutics 2: 589–595 (2003).
Alumna or Alumnus: 
Alumnus
Alumni Title/Position/Employer: 
Manager, Discovery Biology, SuperGen, Inc., Salt Lake City, UT
Career Type: 
Industry